Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases? (Q92017087)

From Wikidata
Jump to navigation Jump to search
scientific article published on 17 April 2020
edit
Language Label Description Also known as
English
Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?
scientific article published on 17 April 2020

    Statements

    Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases? (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit